Bargellini I - Search Results

1

Cost-effectiveness analysis of personalised versus standard dosimetry for selective internal radiation therapy with TheraSphere in patients with hepatocellular carcinoma.

Rognoni C, Barcellona MR, Bargellini I, Bavetta MG, Bellò M, Brunetto M, Carucci P, Cioni R, Crocetti L, D'Amato F, D'Amico M, Deagostini S, Deandreis D, De Simone P, Doriguzzi A, Finessi M, Fonio P, Grimaldi S, Ialuna S, Lagattuta F, Masi G, Moreci A, Scalisi D, Virdone R, Tarricone R. Rognoni C, et al. Among authors: bargellini i. Front Oncol. 2022 Aug 29;12:920073. doi: 10.3389/fonc.2022.920073. eCollection 2022. Front Oncol. 2022. PMID: 36106105 Free PMC article.

2

Doxorubicin-eluting bead-enhanced radiofrequency ablation of hepatocellular carcinoma: a pilot clinical study.

Lencioni R, Crocetti L, Petruzzi P, Vignali C, Bozzi E, Della Pina C, Bargellini I, Cioni D, Oliveri F, De Simone P, Bartolozzi C, Brunetto M, Filipponi F. Lencioni R, et al. Among authors: bargellini i. J Hepatol. 2008 Aug;49(2):217-22. doi: 10.1016/j.jhep.2008.03.021. Epub 2008 Apr 24. J Hepatol. 2008. PMID: 18486261 Clinical Trial.

3

Hepatocellular carcinoma: CT for tumor response after transarterial chemoembolization in patients exceeding Milan criteria--selection parameter for liver transplantation.

Bargellini I, Vignali C, Cioni R, Petruzzi P, Cicorelli A, Campani D, De Simone P, Filipponi F, Bartolozzi C. Bargellini I, et al. Radiology. 2010 Apr;255(1):289-300. doi: 10.1148/radiol.09090927. Radiology. 2010. PMID: 20308465

4

Radiofrequency ablation of lung tumours.

Bargellini I, Bozzi E, Cioni R, Parentini B, Bartolozzi C. Bargellini I, et al. Insights Imaging. 2011 Oct;2(5):567-576. doi: 10.1007/s13244-011-0110-7. Epub 2011 Jul 20. Insights Imaging. 2011. PMID: 22347976 Free PMC article.

5

Outcomes of three years of teamwork on critical limb ischemia in patients with diabetes and foot lesions.

Scatena A, Petruzzi P, Ferrari M, Rizzo L, Cicorelli A, Berchiolli R, Goretti C, Bargellini I, Adami D, Iacopi E, Del Corso A, Cioni R, Piaggesi A. Scatena A, et al. Among authors: bargellini i. Int J Low Extrem Wounds. 2012 Jun;11(2):113-9. doi: 10.1177/1534734612448384. Epub 2012 Jun 3. Int J Low Extrem Wounds. 2012. PMID: 22665920

6

Modified RECIST to assess tumor response after transarterial chemoembolization of hepatocellular carcinoma: CT-pathologic correlation in 178 liver explants.

Bargellini I, Bozzi E, Campani D, Carrai P, De Simone P, Pollina L, Cioni R, Filipponi F, Bartolozzi C. Bargellini I, et al. Eur J Radiol. 2013 May;82(5):e212-8. doi: 10.1016/j.ejrad.2012.12.009. Epub 2013 Jan 15. Eur J Radiol. 2013. PMID: 23332890 Clinical Trial.

7

Trends in utilization of transarterial treatments for hepatocellular carcinoma: results of a survey by the Italian Society of Interventional Radiology.

Bargellini I, Florio F, Golfieri R, Grosso M, Lauretti DL, Cioni R. Bargellini I, et al. Cardiovasc Intervent Radiol. 2014 Apr;37(2):438-44. doi: 10.1007/s00270-013-0656-5. Epub 2013 May 30. Cardiovasc Intervent Radiol. 2014. PMID: 23719667

8

Efficacy and safety of combination therapy with everolimus and sorafenib for recurrence of hepatocellular carcinoma after liver transplantation.

De Simone P, Crocetti L, Pezzati D, Bargellini I, Ghinolfi D, Carrai P, Leonardi G, Della Pina C, Cioni D, Pollina L, Campani D, Bartolozzi C, Lencioni R, Filipponi F. De Simone P, et al. Among authors: bargellini i. Transplant Proc. 2014 Jan-Feb;46(1):241-4. doi: 10.1016/j.transproceed.2013.10.035. Transplant Proc. 2014. PMID: 24507059

9

Identification of responders to sorafenib in hepatocellular carcinoma: is tumor volume measurement the way forward?

Bargellini I, Scionti A, Mismas V, Masi G, Vivaldi C, Bartolozzi C, Sacco R. Bargellini I, et al. Oncology. 2014;86(4):191-8. doi: 10.1159/000358599. Epub 2014 Apr 30. Oncology. 2014. PMID: 24800837

10

Moving beyond sorafenib alone in advanced hepatocellular carcinoma: is hepatic arterial infusion chemotherapy the best option?

Fornaro L, Vivaldi C, Lorenzoni G, Masi G, Bargellini I. Fornaro L, et al. Among authors: bargellini i. Ann Oncol. 2017 Mar 1;28(3):667. doi: 10.1093/annonc/mdw664. Ann Oncol. 2017. PMID: 27993799 Free article. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

113 results

Search Page